Why is Venmax Drugs falling/rising?

As of 19-Sep, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 26.40, reflecting a rise of 1.15 (4.55%). The stock has shown positive momentum, gaining 9.77% over the last two days and outperforming its sector by 4.28% today. It opened with a gain of 4.55% and reached an intraday high of Rs 26.5. However, despite this upward movement, the stock has underperformed in the longer term, with a decline of 3.51% over the past week and 8.97% over the past month. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 91.47% against the 5-day average, indicating potential concerns about sustained interest in the stock.
Broader Market Context: In comparison to the benchmark Sensex, which has gained 0.88% over the past week and 1.20% over the past month, Venmax's short-term performance has lagged behind, despite its recent gains. The stock's year-to-date performance shows a robust increase of 46.34%, significantly outperforming the Sensex's 5.74% gain, suggesting that while the stock is currently rising, it has faced challenges in the short term relative to the broader market. The mixed signals from both the stock's recent performance and the broader market context highlight a complex situation for investors.